- Home
- EVCM vs CNTA Comparison
EVCM vs CNTA Comparison
Compare EVCM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVCM
- CNTA
- Stock Information
- Founded
- EVCM 2006
- CNTA 2020
- Country
- EVCM United States
- CNTA United Kingdom
- Employees
- EVCM N/A
- CNTA N/A
- Industry
- EVCM EDP Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- EVCM Technology
- CNTA Health Care
- Exchange
- EVCM Nasdaq
- CNTA Nasdaq
- Market Cap
- EVCM 1.8B
- CNTA 1.6B
- IPO Year
- EVCM 2021
- CNTA 2021
- Fundamental
- Price
- EVCM $10.01
- CNTA $13.51
- Analyst Decision
- EVCM Buy
- CNTA Strong Buy
- Analyst Count
- EVCM 12
- CNTA 11
- Target Price
- EVCM $11.67
- CNTA $27.00
- AVG Volume (30 Days)
- EVCM 198.4K
- CNTA 730.3K
- Earning Date
- EVCM 05-08-2025
- CNTA 05-14-2025
- Dividend Yield
- EVCM N/A
- CNTA N/A
- EPS Growth
- EVCM N/A
- CNTA N/A
- EPS
- EVCM N/A
- CNTA N/A
- Revenue
- EVCM $703,186,000.00
- CNTA $15,000,000.00
- Revenue This Year
- EVCM N/A
- CNTA N/A
- Revenue Next Year
- EVCM $6.31
- CNTA N/A
- P/E Ratio
- EVCM N/A
- CNTA N/A
- Revenue Growth
- EVCM 7.84
- CNTA 118.88
- 52 Week Low
- EVCM $8.10
- CNTA $7.90
- 52 Week High
- EVCM $12.35
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- EVCM 46.65
- CNTA 56.37
- Support Level
- EVCM $9.66
- CNTA $12.11
- Resistance Level
- EVCM $10.15
- CNTA $13.23
- Average True Range (ATR)
- EVCM 0.39
- CNTA 0.73
- MACD
- EVCM -0.06
- CNTA 0.12
- Stochastic Oscillator
- EVCM 18.39
- CNTA 98.13
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.